Tumor vascular infarction: prospects and challenges

Broad targeting of angiogenesis for cancer prevention and therapy

(2015) Zongwei Wang et al.   SEMINARS IN CANCER BIOLOGY

Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions

(2014) Naveen S. Vasudev et al.   ANGIOGENESIS

Regression of Solid Tumors by Induction of MazF, a Bacterial mRNA Endoribonuclease

(2014) Tsutomu Shimazu et al.   JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY

CD4+ T Cells Modified by the Endoribonuclease MazF Are Safe and Can Persist in SHIV-infected Rhesus Macaques

(2014) Naoki Saito et al.   Molecular Therapy-Nucleic Acids

Mechanisms of resistance to anti-angiogenesis therapies

(2013) Sandy Giuliano et al.   BIOCHIMIE

Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients

(2013) J. E. Geddings et al.   BLOOD

Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales

(2013) Asmaa E El-Kenawi et al.   BRITISH JOURNAL OF PHARMACOLOGY

Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice

(2013) N. Yokota et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Sustained Inhibition of HIV-1 Replication by Conditional Expression of the E. coli-Derived Endoribonuclease MazF in CD4+ T cells

(2013) Mika Okamoto et al.   Human Gene Therapy Methods

Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents

(2013) Marta Cesca et al.   Frontiers in Oncology

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

(2012) Aimery de Gramont et al.   LANCET ONCOLOGY

Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products

(2011) O. Wahl et al.   CURRENT MEDICINAL CHEMISTRY

Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems

(2011) Angelo Corti et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Disrupting established tumor blood vessels

(2010) Mark J. McKeage et al.   CANCER

Flipping the wound that doesn't heal: the upside of coagulation in cancer

(2009) B. A. Teicher   BLOOD

Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience

(2009) R. Bieker et al.   BLOOD

High Efficacy of a Listeria-Based Vaccine against Metastatic Breast Cancer Reveals a Dual Mode of Action

(2009) S. H. Kim et al.   CANCER RESEARCH

Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy

(2009) J. I. Zwicker et al.   CLINICAL CANCER RESEARCH

Tumor-targeting prodrug-activating bacteria for cancer therapy

(2008) C-M Cheng et al.   CANCER GENE THERAPY

Attenuated Salmonella Targets Prodrug Activating Enzyme Carboxypeptidase G2 to Mouse Melanoma and Human Breast and Colon Carcinomas for Effective Suicide Gene Therapy

(2008) F. Friedlos et al.   CLINICAL CANCER RESEARCH

A fusion protein containing murine vascular endothelial growth factor and tissue factor induces thrombogenesis and suppression of tumor growth in a colon carcinoma model

(2008) Feng-ying Huang et al.   Journal of Zhejiang University-SCIENCE B